TY - JOUR
T1 - Electronic nicotine delivery system (ENDS) use in relation to mental health conditions, past-month serious psychological distress and cigarette smoking status, 2017
AU - Spears, Claire Adams
AU - Jones, Dina M.
AU - Weaver, Scott R.
AU - Yang, Bo
AU - Pechacek, Terry F.
AU - Eriksen, Michael P.
N1 - Funding Information:
This research was supported by grant number P50DA036128 from the National Institute on Drug Abuse (NIH/NIDA) and U.S. Food and Drug Administration (FDA) Center for Tobacco Products (CTP) and by grant number K23AT008442 from the National Center for Complementary and Integrative Health (NIH/NCCIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the FDA.
Funding Information:
The authors declare that they have no competing interests. M.P.E. receives research funding support from Pfizer, Inc. (‘Diffusion of Tobacco Control Fundamentals to Other Large Chinese Cities’, Michael Eriksen, Principal Investigator). No financial disclosures are reported by the other authors of this paper.
Publisher Copyright:
© 2018 Society for the Study of Addiction
PY - 2019/2/1
Y1 - 2019/2/1
N2 - Background and Aims: Adults with mental health conditions (MHC) exhibit disproportionately high smoking prevalence and experience profound tobacco-related disparities. US nationally representative surveys from 2012 to 2015 found relatively high usage of electronic nicotine delivery systems (ENDS; e.g. e-cigarettes) among adults with MHC. However, research has not examined these associations specifically among never smokers. Aims were to examine associations among MHC diagnosis, serious psychological distress (SPD) and ENDS use and to test whether associations varied by cigarette smoking status. Design: Cross-sectional US nationally representative survey. Setting: United States, 2017. Participants: A total of 5762 adults (52.0% female; 64.8% non-Hispanic white, 11.4% non-Hispanic black, 15.9% Hispanic, 7.9% non-Hispanic other). Measurements: Outcomes were lifetime, current and current daily ENDS use. Predictors were lifetime MHC, past-month SPD and cigarette smoking status, and covariates were gender, age, race/ethnicity, education and annual household income. Findings: lifetime MHC and past-month SPD were each associated with higher likelihood of having ever used ENDS (P ≤ 0.001), currently using ENDS (P ≤ 0.001) and currently using ENDS daily (P < 0.05). There were interactions between MHC and smoking status in predicting ENDS use, such that MHC status predicted higher lifetime and current ENDS use specifically among never and current smokers. Never smokers with MHC had 2.62 higher odds [95% confidence interval, (CI) = 1.54, 4.45] of current ENDS use than those without MHC. Among never smokers, those with MHC indicated higher expectations that ENDS would improve relaxation and concentration (P < 0.05). Conclusions: In 2017, US adults with versus without mental health conditions (MHC) were more likely to use electronic nicotine delivery systems (ENDS). In particular, both never and current smokers with MHC reported disproportionately high rates of current ENDS use.
AB - Background and Aims: Adults with mental health conditions (MHC) exhibit disproportionately high smoking prevalence and experience profound tobacco-related disparities. US nationally representative surveys from 2012 to 2015 found relatively high usage of electronic nicotine delivery systems (ENDS; e.g. e-cigarettes) among adults with MHC. However, research has not examined these associations specifically among never smokers. Aims were to examine associations among MHC diagnosis, serious psychological distress (SPD) and ENDS use and to test whether associations varied by cigarette smoking status. Design: Cross-sectional US nationally representative survey. Setting: United States, 2017. Participants: A total of 5762 adults (52.0% female; 64.8% non-Hispanic white, 11.4% non-Hispanic black, 15.9% Hispanic, 7.9% non-Hispanic other). Measurements: Outcomes were lifetime, current and current daily ENDS use. Predictors were lifetime MHC, past-month SPD and cigarette smoking status, and covariates were gender, age, race/ethnicity, education and annual household income. Findings: lifetime MHC and past-month SPD were each associated with higher likelihood of having ever used ENDS (P ≤ 0.001), currently using ENDS (P ≤ 0.001) and currently using ENDS daily (P < 0.05). There were interactions between MHC and smoking status in predicting ENDS use, such that MHC status predicted higher lifetime and current ENDS use specifically among never and current smokers. Never smokers with MHC had 2.62 higher odds [95% confidence interval, (CI) = 1.54, 4.45] of current ENDS use than those without MHC. Among never smokers, those with MHC indicated higher expectations that ENDS would improve relaxation and concentration (P < 0.05). Conclusions: In 2017, US adults with versus without mental health conditions (MHC) were more likely to use electronic nicotine delivery systems (ENDS). In particular, both never and current smokers with MHC reported disproportionately high rates of current ENDS use.
KW - Cigarettes
KW - e-cigarette outcome expectations
KW - e-cigarettes
KW - electronic nicotine delivery systems
KW - mental health conditions
KW - psychological distress
UR - http://www.scopus.com/inward/record.url?scp=85056140308&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056140308&partnerID=8YFLogxK
U2 - 10.1111/add.14464
DO - 10.1111/add.14464
M3 - Article
C2 - 30291763
AN - SCOPUS:85056140308
SN - 0965-2140
VL - 114
SP - 315
EP - 325
JO - Addiction
JF - Addiction
IS - 2
ER -